Cytotoxicity of substituted benzimidazolyl curcumin mimics against multi-drug resistance cancer cell

Bulletin of the Korean Chemical Society

Volumn 34, Issue 4, 2013, Pages 1272-1274

  Eom, Young Woo ^a   Oh, Sangtae ^b   Woo, Ho Bum ^a   Ham, Jungyeob ^c   Ahn, Chan Mug ^b   Lee, Seokjoon ^b  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Benzimidazole; Curcumin; Curcumin mimics; Cytotoxicity; Multi drug resistance

Indexed keywords

EID: 84877754850     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2013.34.4.1272     Document Type: Article

References (26)

1. Srimal, R. C.; Dhawan, B. N. J. Pharm. Pharmacol. 1973, 25, 447.
2. Sharma, O. P. Biochem. Pharmacol. 1976, 25, 1811.
3. Li, C. J.; Zhang, L. J.; Dezube, B. J.; Crumpacker, C. S.; Pardee, A. B. Proc. Natl. Acad. Sci. 1993, 90, 1839.
4. Kawamori, T.; Lubet, R.; Steele, V. E.; Kelloff, G. J.; Kaskey, R. B.; Rao, C. V.; Reddy, B. S. Cancer Res. 1999, 59, 597.
5. Brouet, I.; Ohshima, H. Biochem. Biophys. Res. Commun. 1995, 206, 533.
6. Sidhu, G. S.; Mani, H.; Gaddipati, J. P.; Singh, A. K.; Seth, P.; Banaudha, K. K.; Patnaik, G. K.; Maheshwari, R. K. Wound Rep. Reg. 1999, 7, 362.
7. Woo, H. B.; Shin, W.-S.; Lee, S.; Ahn, C. M. Bioorg. Med. Chem. Lett. 2005, 15, 3782.
8. Ahn, C. M.; Park, B.-G.; Woo, H. B.; Ham, J.; Lee, S. Bioorg. Med. Chem. Lett. 2009, 19, 1481.
9. Park, S.-K.; Oh, S.; Shin, H. K.; Kim, S. H.; Ham, J.; Song, J.-S.; Lee, S. Bioorg. Med. Chem. Lett. 2011, 21, 3573.
10. Woo, H. B.; Eom, Y. W.; Park, K.-S.; Ham, J.; Ahn, C. M.; Lee, S. Bioorg. Med. Chem. Lett. 2012, 22, 933.
11. Nofal, Z. M.; Soliman, E. A.; El-Karim, S. S. A.; El-Zahar, M. I.; Srou, A. M.; Sethumadhavan, S.; Maher, T. J. Acta. Pol. Pharm.-Drug Res. 2011, 68, 519.
12. Porcari, A. R.; Devivar, R. V.; Kucera, L. S.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1998, 41, 1252.
13. Kumar, J. R.; Jawahar, J. L.; Pathak, D. P. E-J. Chem. 2006, 3, 278.
14. Aouali, N.; Eddabra, L.; Macadré, J.; Morjani, H. Crit. Rev. Oncol./ Hematol. 2005, 56, 61.
15. Chearwae, W.; Anuchapreeda, S.; Nandigama, K.; Ambudkar, S. V.; Limtrakul, P. Biochem. Pharmacol. 2004, 68, 2043.
16. Anuchapreeda, S.; Leechanachai, P.; Smith, M. M.; Ambudkar, S. V.; Limtrakul, P. Biochem. Pharmacol. 2002, 64, 573.
17. Romiti, N.; Tongiani, R.; Cervelli, F.; Chieli, E. Life Sci. 1998, 62, 2349.
18. Kim, Y. K.; Song, Y. J.; Seo, D. W.; Kang, D. W.; Lee, H. Y.; Rhee, D. K.; Han, J. W.; Ahn, C. M.; Lee, S.; Kim, S. N. Biochem. Biophys. Res. Commun. 2007, 355, 136.
19. Um, Y.; Cho, S.; Woo, H. B.; Kim, Y. K.; Kim, H.; Ham, J.; Kim, S. N.; Ahn, C. M.; Lee, S. Bioorg. Med. Chem. 2008, 16, 3608.
20. Orjales, A.; Alonso-Cires, L.; López-Tudanca, P.; Tapia, I.; Mosquera, R.; Labeaga, L. Eur. J. Med. Chem. 1999, 34, 415.
21. Roggen, H.; Charnock, C.; Gundersen, L.-L. Tetrahedron 2009, 65, 5199.
22. Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
23. Matarrese, M.; Soloviev, D. V.; Moresco, R. M.; Ferri, V.; Simonelli, P.; Magni, F.; Colombo, F.; Todde, S.; Carpinelli, A.; Fazio, F.; Kienle, M. G. Bioorg. Chem. 1998, 26, 91.
24. OVCAR-8 and NCI/ADR-RES cells overexpressing P-gp were obtained from National Cancer Institute (Frederick, MD). These cells were maintained in RPMI 1640 culture medium containing 10% FBS and antibiotics (100 U/mL penicillin G and 100 μg/mL streptomycin). All experiments were carried out 24 h after cells were seeded. Chemical compounds were dissolved in DMSO and diluted with DMEM medium to final concentrations of 1 nM to 100 μM. OVCAR-8 and NCI/ADR-RES cells were incubated with chemical compounds for 48 h and then the MTT assay was performed. A 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide (MTT) reduction was determined to examine the effect of chemical compounds on cell viability. Briefly, following the treatment of cells with different concentrations of chemical compound (final concentration, 1 nM, 10 nM, 100 nM, 1 μM, 10 μM, and 100 μM) for 48 h, cells were incubated with MTT solution (0.5 mg/mL) for 3 h at 37 oC. The violet precipitate (formazan) in MTTtreated cells was dissolved with 100 μL of DMSO and then analyzed at a wavelength of 595 nm with a microplate reader (Beckman Coulter, Brea, CA). Each assay was performed in triplicate.
25. Qiang, F.; Lee, B.-J.; Ha, I.; Kang, K. W.; Woo, E.-R.; Han, H.-K. Eur. J. Pharm. Sci. 2010, 41, 226.
26. Lu, J.-J.; Cai, Y.-J.; Ding, J. Mol. Cell Biochem. 2012, 360, 253.